🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥

Startup Showcase

Premium Content

Try our Valuation Calculator →

News on Medial

PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stake

Economic Times

Economic Times · 2y ago

PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stake

PharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per share that it secured in 2021. The huge fall in value has triggered questions about the fate of Velumani’s purchase of a 5% stake in the firm in 2021 when it was valued at $4 billion.

Related News

Manipal Group to invest ₹1,000 crore in PharmEasy: Report

Inshorts · 2y ago

Manipal Group to invest ₹1,000 crore in PharmEasy: Report

According to Moneycontrol, API Holdings, the parent company of online pharmacy PharmEasy and promoter of Thyrocare, is in talks for a fundraising initiative to repay its debt. The Manipal Group has shown interest in investing around ₹1,000 crore for an 18% stake in API Holdings, which would result in a post-money valuation. Additionally, the Manipal Group may secure a position on the API Holdings board.

PharmEasy-Owned Thyrocare to acquire Think Health diagnostics to offer ECG services at home

Inc42 · 1y ago

PharmEasy-Owned Thyrocare to acquire Think Health diagnostics to offer ECG services at home

Thyrocare, a diagnostics platform owned by PharmEasy, is acquiring Chennai-based Think Health Diagnostics to offer ECG services at home. The acquisition will also help Thyrocare tap into the insurance segment. Think Health Diagnostics currently operates in 10 cities across India. The deal will create a phlebotomy network with over 100 phlebotomists trained in providing ECG services. API Holdings, the parent company of PharmEasy, acquired a majority stake in PharmEasy in 2021.

PharmEasy’s CEO Siddharth Shah steps down; Thyrocare chief Rahul Guha to take over

Entrackr

Entrackr · 22d ago

PharmEasy’s CEO Siddharth Shah steps down; Thyrocare chief Rahul Guha to take over

Siddharth Shah, cofounder and current MD and CEO of API Holdings, the parent company of PharmEasy and Thyrocare, is stepping down from his executive role. He will take on the role of Vice Chairman and Director of the company effective August 27, 2025. Rahul Guha, who currently serves as the MD and CEO of Thyrocare, will take over as the new MD and CEO of API Holdings. The announcement was made through regulatory filings by Thyrocare on Wednesday and is part of a wider leadership transition within the group. Guha will continue to lead Thyrocare alongside his new responsibilities at API. Before this appointment, Guha held the position of President of Operations at API, where he was responsible for overseeing integration and coordination across the group companies. For background, PharmEasy had acquired a majority stake (66.1%) in Thyrocare for Rs 4,546 crore in June 2021. Guha’s appointment reflects API’s focus on consolidating leadership across verticals as the company navigates a difficult funding environment and prepares for a possible public listing. API had filed draft IPO papers in 2021 but later withdrew them due to market conditions. PharmEasy has raised about $1.1 billion from investors including MEMG, Prosus, and Temasek. In April 2024, it secured $216 million at a steep 90% drop in valuation to $710 million. Earlier this year, PharmEasy’s three cofounders Dharmil Sheth, Dhaval Shah, and Hardik Dedhia stepped back from the Bengaluru-based firm. They recently launched their new venture All Home. The company secured an undisclosed investment round led by Bessemer Venture Partners at a valuation of more than $120 million, with Siddharth Shah also participating as an investor.

Thyrocare Founder Partners YEA, Magnifiq Capital Trust To Infuse Up To INR 50 Cr Into Startups

Inc42 · 1y ago

Thyrocare Founder Partners YEA, Magnifiq Capital Trust To Infuse Up To INR 50 Cr Into Startups

Thyrocare founder Arokiaswamy Velumani has partnered with Young Entrepreneurs Association (YEA) and Magnifiq Capital Trust to invest up to INR 50 Cr in Indian startups. This initiative not only involves financial support but also mentorship for promising startups. Velumani plans to target seed-stage startups with significant growth potential and a minimum turnover of INR 5 Cr. YEA, established in 2012, provides support, mentorship, and investments to startups. Thyrocare recently acquired a 66% stake in Thyrocare for INR 4,546 Cr.

Zepto is currently where Amazon was in 1990s: Co-founder Palicha

Inshorts · 1y ago

Zepto is currently where Amazon was in 1990s: Co-founder Palicha

Zepto is currently in a position similar to where Amazon was in the late 1990s and early 2000s and may hit a valuation of $50-$80 billion, CEO and Co-founder Aadit Palicha said at Moneycontrol Startup Conclave 2024. "It's largely just execution so it's not guaranteed. There were...companies in the past who could've done that but couldn't execute it," Palicha said.

PharmEasy parent API Holdings clocks ₹60 Cr EBITDA in H1 FY24

YourStory

YourStory · 1y ago

PharmEasy parent API Holdings clocks ₹60 Cr EBITDA in H1 FY24

API Holdings, the parent company of PharmEasy, Docon, Thyrocare, and Retailio, has reported a cumulative EBITDA of Rs 60 crore for the April to September period of 2023. The company aimed for profitability by April 2023 and has achieved positive EBITDA for all six months of FY24. API Holdings also launched a rights issue worth Rs 3,500 crore, which has been oversubscribed. Ranjan Pai, Founder of Manipal Health Enterprises, has agreed to invest Rs 1,200 crore. Axelia Solutions Pvt Ltd, the operator of PharmEasy's platform, reported a revenue of Rs 256 crore and reduced losses for the financial year ended March 2023.

Can one tweet erode ₹3,500 crore value in 2 hours: Velumani on Ola Electric

Inshorts · 10m ago

Can one tweet erode ₹3,500 crore value in 2 hours: Velumani on Ola Electric

Thyrocare Founder A Velumani posted on X, "Can one tweet erode ₹3,500 crore of value for a company in 2 hours...Or reason is not tweet." His tweet came as Ola Electric's share fell 9% on Monday amid CEO Bhavish Aggarwal's feud with comedian Kunal Kamra on X. "Reason is poor fundamentals not tweets," an X user said on Velumani's post.

A reset is on cards at Byju’s cap table post rights issue value cut

Economic Times

Economic Times · 1y ago

A reset is on cards at Byju’s cap table post rights issue value cut

Edtech firm Byju's is proposing a rights issue at a significant cut to its peak valuation. The move aims to secure funding quickly and alleviate pressures from investors concerned about the founder's involvement in the company's operations. Existing investors who do not participate in the rights issue may see their stake fully erode. Byju Raveendran, the founder, may end up owning a larger portion of the firm if successful in arranging financing. The rights issue is open for 30 days, and discussions with investors are expected to begin soon.

Grapevine: Haldiram's stake sale hits stalemate; French firm checks into New Shop

VCCircle

VCCircle · 11m ago

Grapevine: Haldiram's stake sale hits stalemate; French firm checks into New Shop

The stake sale process for Haldiram Snacks Food Pvt Ltd has encountered a roadblock due to disagreements over pricing and valuation. The Blackstone-led consortium, which includes GIC and the Abu Dhabi Investment Authority, had submitted a non-binding bid valuing the company at over $8 billion in May. However, negotiations have hit a stalemate. On a different note, a French firm has recently made an investment in New Shop, a retail-tech startup.

OpenAI Co-founder Ilya's startup seeks $20 bn valuation: Report

Inshorts · 6m ago

OpenAI Co-founder Ilya's startup seeks $20 bn valuation: Report

OpenAI Co-founder Ilya Sutskever's startup Safe Superintelligence (SSI) is in talks to raise funding at a $20 billion valuation, Reuters reported. The startup, which has not generated any revenue yet, raised $1 billion in September last year at a reportedly $5 billion valuation. Sutskever launched SSI in June 2024 after leaving OpenAI in May.

Trackers

Active Indian VC’s

OG Capital Email

With a hands-on approach, OG Capital aims to invest in over 20 promising...

Accel Partners Email

Early and growth-stage investments in disruptive technology companies with...

Early-stage venture capital firm investing in technology startups in India. Focus on...

Access All Trackers

Startup Showcase Winners

June 2025

Helping your parents when you are miles away

The Pit Stop Your Cravings Deserve

The next generation E-commerce platform

Enter Ongoing Startup Showcase

Top Users

Trending News on Medial

Just Months After Promotion, Open ...

Exclusive: Robotics startup Miko ...

“Your Phone Is Outdated”: Sam Alt ...

Download the medial app to read full posts, comements and news.